| | |
n = 32(%)
|
|---|
|
Age, mean ± SD
| |
53.6 ± 12.2
|
|
Hormone receptor
|
positive
|
14 (43.8)
|
|
negative
|
18 (56.2)
|
|
TNBC
| |
16 (50)
|
|
PS
|
0
|
19 (59.4)
|
|
1
|
13 (40.6)
|
|
Prior treatment
|
Anthracycline
|
23 (71.9)
|
|
Taxane
|
29 (90.6)
|
|
Prior regimen number
|
0
|
11 (34.4)
|
|
1
|
14 (43.8)
|
|
2
|
7 (21.9)
|
|
Visceral metastasis
|
present
|
22 (68.8)
|
|
Number of metastases
|
1
|
28 (87.5)
|
|
2
|
2 (6.3)
|
|
3
|
1 (3.1)
|
|
4
|
1 (3.1)
|
|
Metastatic sites
|
Liver
|
14
|
|
Lymph node
|
10
|
|
Lung
|
8
|
|
Skin
|
3
|
|
Pleural
|
1
|
|
Breast
|
1
|
|
Thyroid
|
1
|
|
Spleen
|
1
|
- Abbreviations: OR Oestrogen receptor, PgR Progesterone receptor, HER-2 Human epidermal growth factor receptor 2, PS Performance status
